193 related articles for article (PubMed ID: 22235676)
1. [Appropriate prolongation of GnRH-a down-regulation improves the synchronism of follicular development].
Wang B; Sun HX; Liu JY; Hu YL; He FF
Zhonghua Nan Ke Xue; 2011 Dec; 17(12):1087-91. PubMed ID: 22235676
[TBL] [Abstract][Full Text] [Related]
2. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
4. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone, estradiol, and inhibin regulation of follicle-stimulating hormone and luteinizing hormone surges: implications for follicle emergence and selection in heifers.
Haughian JM; Ginther OJ; Diaz FJ; Wiltbank MC
Biol Reprod; 2013 Jun; 88(6):165. PubMed ID: 23658431
[TBL] [Abstract][Full Text] [Related]
6. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
[TBL] [Abstract][Full Text] [Related]
7. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development.
Lainas TG; Petsas GK; Zorzovilis IZ; Iliadis GS; Lainas GT; Cazlaris HE; Kolibianakis EM
Hum Reprod; 2007 Jun; 22(6):1540-6. PubMed ID: 17347165
[TBL] [Abstract][Full Text] [Related]
8. Influence of synthetic lamprey GnRH-III on gonadotropin release and steroid hormone levels in gilts.
Brüssow KP; Schneider F; Tuchscherer A; Kanitz W
Theriogenology; 2010 Dec; 74(9):1570-8. PubMed ID: 20708243
[TBL] [Abstract][Full Text] [Related]
9. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
Ye H; Huang G; Pei L
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
[TBL] [Abstract][Full Text] [Related]
10. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone.
Jayaprakasan K; Campbell BK; Hopkisson JF; Clewes JS; Johnson IR; Raine-Fenning NJ
Hum Reprod; 2008 Nov; 23(11):2577-83. PubMed ID: 18658161
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
12. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
13. Acute follicular response to FSH in heifers downregulated long term with a GnRH agonist and with suppressed ovarian follicular growth.
D'Occhio MJ; Cremonesi F; Trigg TE; Aspden WJ; Baruselli PS
Theriogenology; 2013 Dec; 80(9):999-1005. PubMed ID: 23998741
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone-induced ovulation and luteinizing hormone release in beef heifers: effect of day of the cycle.
Atkins JA; Busch DC; Bader JF; Keisler DH; Patterson DJ; Lucy MC; Smith MF
J Anim Sci; 2008 Jan; 86(1):83-93. PubMed ID: 17911234
[TBL] [Abstract][Full Text] [Related]
16. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
Schipper I; Hop WC; Fauser BC
J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
[TBL] [Abstract][Full Text] [Related]
17. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome.
Filicori M; Cognigni GE; Taraborrelli S; Spettoli D; Ciampaglia W; de Fatis CT; Pocognoli P
J Clin Endocrinol Metab; 1999 Aug; 84(8):2659-63. PubMed ID: 10443656
[TBL] [Abstract][Full Text] [Related]
18. Progesterone concentration, estradiol pretreatment, and dose of gonadotropin-releasing hormone affect gonadotropin-releasing hormone-mediated luteinizing hormone release in beef heifers.
Dias FC; Colazo MG; Kastelic JP; Mapletoft RJ; Adams GP; Singh J
Domest Anim Endocrinol; 2010 Oct; 39(3):155-62. PubMed ID: 20580523
[TBL] [Abstract][Full Text] [Related]
19. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
